Evidence map›Paper›PMID 29439417›Full record

ReviewMarine drugs2018

Recent Advances in Antibacterial and Antiendotoxic Peptides or Proteins from Marine Resources.

Zhenlong Wang, Xiumin Wang, Jianhua Wang

Abstract readReview
In one paragraph

Review in Marine drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. ACS omega · 2020
    Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zhenlong WangKey Laboratory of Feed Biotechnology, Ministry of Agriculture, Beijing 100081, China. 429524082@qq.com.
Xiumin WangKey Laboratory of Feed Biotechnology, Ministry of Agriculture, Beijing 100081, China. wangxiumin@caas.cn.ORCID 0000-0002-2008-856X
Jianhua WangKey Laboratory of Feed Biotechnology, Ministry of Agriculture, Beijing 100081, China. wangjianhua@caas.cn.ORCID 0000-0002-4048-6055

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious diseases caused by Gram-negative bacteria and sepsis induced by lipopolysaccharide (LPS) pose a major threat to humans and animals and cause millions of deaths each year. Marine organisms are a valuable resource library of bioactive products with huge medicinal potential. Among them, antibacterial and antiendotoxic peptides or proteins, which are composed of metabolically tolerable residues, are present in many marine species, including marine vertebrates, invertebrates and microorganisms. A lot of studies have reported that these marine peptides and proteins or their derivatives exhibit potent antibacterial activity and antiendotoxic activity in vitro and in vivo. However, their categories, heterologous expression in microorganisms, physicochemical factors affecting peptide or protein interactions with bacterial LPS and LPS-neutralizing mechanism are not well known. In this review, we highlight the characteristics and anti-infective activity of bifunctional peptides or proteins from marine resources as well as the challenges and strategies for further study.

Indexed as

AnimalsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesEndotoxinsHumansLipopolysaccharidesMarine BiologyMarine ToxinsPeptidesAnti-Bacterial AgentsAntimicrobial Cationic PeptidesEndotoxinsLipopolysaccharidesMarine ToxinsPeptidesantibacterial activityantiendotoxic activitylipopolysaccharidemarine resourcesneutralization

Identifiers

PMID29439417
PMCPMC5852485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.